Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004

Maria Teresa Esposito

Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004

Maria Teresa Esposito

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	“Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004
Publication status	Published - 2004

Cite this

Esposito, M. T. (2004). Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. In “Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004

Esposito, Maria Teresa. / Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. “Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. 2004.

@inproceedings{d170e1ccd6b14fa59e1b8aa44728bcc7,

title = "Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004",

author = "Esposito, {Maria Teresa}",

year = "2004",

language = "English",

booktitle = "“Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004",

}

Esposito, MT 2004, Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. in “Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004.

Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. / Esposito, Maria Teresa.
“Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. 2004.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004

AU - Esposito, Maria Teresa

PY - 2004

Y1 - 2004

M3 - Conference contribution

BT - “Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004

ER -

Esposito MT. Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. In “Expression of bone morphogenetic protein-4 via adenoviral vector in mesenchymal stem cells induces differentiation into the osteoblastic lineage.” European Society of Gene Therapy Tampere, Finland 2004. 2004